Side-by-side comparison of AI visibility scores, market position, and capabilities
NYC YC W20 prize-linked savings/sweepstakes fintech at 700K+ members; severely impacted by Synapse bankruptcy May 2024 leaving 85K customers unable to access $112M in deposits; $17.9M total ($13.2M Base10 Series A 2021).
Yotta is a New York-based fintech company — backed by Y Combinator (W20) with $17.9-21.2 million in total funding including a $13.2 million Series A in January 2021 led by Base10 Partners with Y Combinator, Core Innovation Capital, and Slow Ventures — offering sweepstakes games with a member base of 700,000+ people, after previously operating prize-linked savings accounts before being severely impacted by the Synapse Financial Technologies bankruptcy in May 2024. When Synapse (Yotta's banking-as-a-service middleware partner) failed, approximately 85,000 Yotta customers with $112 million in deposits lost account access — and as of November 2024, 13,725 depositors were offered only $11.8 million of $64.9 million in claimed deposits, illustrating the systemic risk that BaaS middleware dependency creates for fintech customer funds.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.